Psychological treatments for the management of irritable bowel syndrome (Q24241516)

2

0 references

Geert J van der Heijden

3

0 references

Gregory Rubin

4

0 references

A Otto Quartero

Cochrane Database of Systematic Reviews

5

0 references

publication date

21 January 2009

0 references

published in

0 references

cites work

A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A comparison of psychological and medical treatment of the irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Psychological changes associated with self-regulatory treatments of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Psychological assessment and treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Prediction of treatment outcome among patients with irritable bowel syndrome treated with group cognitive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A collaborative health care model for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A Randomised Controlled Trial of Psychotherapy in Patients with Refractory Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Self-management for women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Effects of fasting therapy on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A one year follow-up of relaxation response meditation as a treatment for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A randomized trial of yoga for adolescents with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive behavior therapy for functional gastrointestinal disorders: is group treatment effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Preliminary study of a self-administered treatment for irritable bowel syndrome: comparison to a wait list control group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Behavioral treatment of irritable bowel syndrome: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Behaviorally treated irritable bowel syndrome patients: a four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive-behavioral group therapy for patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive-Behavioral Therapy in the Treatment of Anger: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Functional gastrointestinal disorders: psychological, social, and somatic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Relative contribution of specific and nonspecific treatment effects: meta-analysis of placebo-controlled behavior therapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive behaviour therapy in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Irritable bowel syndrome: a technical review for practice guideline development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Design of treatment trials for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Brain-gut connections in functional GI disorders: anatomic and physiologic relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

21 January 2018

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

A 1- and 2-year follow-up study of bowel sound biofeedback as a treatment for irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Relaxation training as a treatment for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Adaptation of a multicomponent treatment for irritable bowel syndrome to a small-group format

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Bowel sound biofeedback as a treatment for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Impact of irritable bowel syndrome on quality of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Use and abuse of placebo in phase III trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Controlled treatment trials in the irritable bowel syndrome: a critique.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

A controlled trial of psychological treatment for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Behavioural psychotherapy in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Survey of the AGA membership relating to patients with functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Controlled study of psychotherapy in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Stress management and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Cognitive therapy for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioral and psychodynamic-interpersonal psychotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Stress Management for Irritable Bowel Syndrome: A Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

Psychodrama group therapy for patients with functional gastrointestinal disorders--a controlled long-term follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021

A psychosomatic approach to treatment in the irritable bowel syndrome and peptic ulcer disease with aspects of the design of clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006442.PUB2

7 January 2021